Position in PFE
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$176,843
-$29,376 QoQ
Shares Held
7,344
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
2.46%
of 13F equity value
Holder Rank
#2,472
of 2,821 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Spurstone Advisory Services, LLC holds $225,402 across 3 Drug Manufacturers - General names. PFE ranks #1 (78.5% of the industry book) .
All Filings in PFE
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $176,843 | 7,344 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $206,219 | 7,344 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $182,865 | 7,344 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $203,916 | 8,003 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $193,992 | 8,003 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $202,796 | 8,003 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $246,808 | 9,303 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||